The most reasonable candidate gene for the amplified region would be FOXO1, functioning as a transcriptional regulator and known to harbor recurrent oncogenic hotspot mutations in lymphomas enabling nuclear retention and avoidance of cytoplasmic inactivation.25 This evidence concerns the gene FOXO1 and lymphoma.